The previously developed mathematical model simulates the CD4(+) lymph
ocyte dynamics in HIV infection very well. As the number of these cell
s is a good indicator of the infection progression, it was used to eva
luate the effectiveness of different therapeutic interventions. For ch
emotherapy simulation, both permanent and temporary zinovudine (AZT) a
dministration were considered and the induced return of the CD4(+) lym
phocyte counts was analysed. Similar analysis was performed for active
and passive immunotherapy. The model offers also the possibility of s
timulating the CD4(+) dynamics after depletion of CD8(+) lymphocytes b
y antibodies. Even one simulated administration of anti-CD8 antibodies
increases the CD4(+) lymphocyte counts and prolongs the survival of t
he patient. However, if cells involved in protective immunity are assu
med to belong to the CD8(+) category, anti-CD8 antibodies accelerate t
he decrease of CD4(+) cells and thus shorten the patient's survival.